Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Development and characterization of an Sf-1-Flp mouse model
Marco Galvan, … , Joel K. Elmquist, Teppei Fujikawa
Marco Galvan, … , Joel K. Elmquist, Teppei Fujikawa
Published March 4, 2025
Citation Information: JCI Insight. 2025;10(8):e190105. https://doi.org/10.1172/jci.insight.190105.
View: Text | PDF
Research Article Metabolism Neuroscience

Development and characterization of an Sf-1-Flp mouse model

  • Text
  • PDF
Abstract

The use of genetically engineered tools, including combinations of Cre-LoxP and Flp-FRT systems, enables the interrogation of complex biology. Steroidogenic factor-1 (SF-1) is expressed in the ventromedial hypothalamic nucleus (VMH). Development of genetic tools, such as mice expressing Flp recombinase (Flp) in SF-1 neurons (Sf-1-Flp), will be useful for future studies that unravel the complex physiology regulated by the VMH. Here, we developed and characterized Sf-1-Flp mice and demonstrated their utility. The Flp sequence was inserted into the Sf-1 locus with P2A. This insertion did not affect Sf-1 mRNA expression levels and Sf-1-Flp mice do not have any visible phenotypes. They are fertile and metabolically comparable to wild-type littermate mice. Optogenetic stimulation using adeno-associated virus (AAV) carrying Flp-dependent channelrhodopsin-2 (ChR2) increased blood glucose and skeletal muscle PGC-1α in Sf-1-Flp mice. This was similar to SF-1 neuronal activation using Sf-1-BAC-Cre and AAV carrying Cre-dependent ChR2. Finally, we generated Sf-1-Flp mice that lack β2-adrenergic receptors (Adrb2) only in skeletal muscle with a combination of Cre/LoxP technology (Sf-1-Flp:SKMΔAdrb2). Optogenetic stimulation of SF-1 neurons failed to increase skeletal muscle PGC-1α in Sf-1-Flp:SKMΔAdrb2 mice, suggesting that Adrb2 in skeletal muscle is required for augmented skeletal muscle PGC-1α by SF-1 neuronal activation. Our data demonstrate that Sf-1-Flp mice are useful for interrogating complex physiology.

Authors

Marco Galvan, Mina Fujitani, Samuel R. Heaselgrave, Shreya Thomas, Bandy Chen, Jenny J. Lee, Steven C. Wyler, Joel K. Elmquist, Teppei Fujikawa

×

Figure 5

Adrb2 in skeletal muscle cells is required for augmented skeletal muscle Ppargc1a mRNA by VMHSF-1 neuronal activation.

Options: View larger image (or click on image) Download as PowerPoint

Adrb2 in skeletal muscle cells is required for augmented skeletal muscl...
(A) Experimental design to generate mice lacking Adrb2 in skeletal muscle cells (Sf-1-Flp:SKMΔAdrb2) and expressing ChR2 in VMHSF-1 neurons (Sf-1-Flp:SKMΔAdrb2:ChR2). AAV-fDIO-EYFP was used as control AAV for AAV-fDIO-ChR2 (Sf-1-Flp:SKMΔAdrb2:EYFP). A control group that does not lack Adrb2 in skeletal muscle cells (control) was also administered either AAV-fDIO-EYFP or AAV-fDIO-ChR2 (Control:EYFP or Control:ChR2). (B) Blood glucose levels of Sf-1-Flp:SKMΔAdrb2:ChR2 mice after optogenetic stimulation. (C–H) mRNA expression levels of Ppargc1a isoform in skeletal muscle of Sf-1-Flp:SKMΔAdrb2:ChR2 mice after optogenetic stimulation. All mice were male. Values are mean ± SEM (n = 4–6). *P < 0.05, ***P < 0.001. Detailed statical analysis is described in Supplemental Table 3. Briefly, 2-way repeated-measures ANOVA was used in B, and 2-way ANOVA was used in C–E, G, and H. Šidák’s multiple-comparison test or the 2-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli was used for the post hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts